Announcement of TTY Biopharm's unaudited income information in Jan 2020
2020.2.10
Provided by: TTY BIOPHARM COMPANY LIMITED
| SEQ_NO | 1 | Date of announcement | 2020/02/10 | Time of announcement | 18:18:26 |
| Subject | Announcement of TTY Biopharm's unaudited income information in Jan 2020 | ||||
| Date of events | 2020/02/10 | To which item it meets | paragraph 53 | ||
| Statement | 1.Date of occurrence of the event:2020/02/10 2.Company name:TTY Biopharm Co., Ltd. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office 4.Reciprocal shareholding ratios:N/A 5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $370,093 thousands(expressed in NT dollars; unaudited), a consolidated operating profit of $106,362 thousands, and a consolidated income before tax of $123,974 thousands in Jan 2020; net income attributed to stockholders of the company was $96,238 thousands; EPS is $0.39. 6.Countermeasures:N/A 7.Any other matters that need to be specified:The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail. |
||||